Alcon Terminates Agreement to Acquire STAAR Surgical

Reuters01-07
Alcon Terminates Agreement to Acquire STAAR Surgical

Alcon has terminated its definitive merger agreement with STAAR Surgical Company, originally announced on August 5, 2025. According to Alcon CEO David J. Endicott, the company remained disciplined regarding price and risk throughout the process. Alcon’s refractive strategy remains unchanged, with continued focus on its new wavelight® plus offering for LASIK and ongoing global launches of more than 10 major products in its surgical and vision care franchises.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alcon AG published the original content used to generate this news brief via Business Wire (Ref. ID: 20260106685027) on January 07, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment